pentobarbital has been researched along with Developmental Disabilities in 4 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
Developmental Disabilities: Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentobarbital and fentanyl were the two most common medications used for sedation in children with and without developmental disability." | 1.35 | Sedation medication received and adverse events related to sedation for brain MRI in children with and without developmental disabilities. ( Chen, X; Groebe, A; Kannikeswaran, N; Mahajan, PV; Sethuraman, U, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kannikeswaran, N | 2 |
| Mahajan, PV | 1 |
| Sethuraman, U | 2 |
| Groebe, A | 1 |
| Chen, X | 2 |
| Raveendran, R | 1 |
| Korula, G | 1 |
| Joselyn, AS | 1 |
| Pothapragada, KC | 1 |
| Elwood, T | 1 |
| Hansen, LD | 1 |
| Seely, JM | 1 |
4 other studies available for pentobarbital and Developmental Disabilities
| Article | Year |
|---|---|
Sedation medication received and adverse events related to sedation for brain MRI in children with and without developmental disabilities.
Topics: Adolescent; Anesthetics, Intravenous; Brain; Child; Child, Preschool; Conscious Sedation; Developmen | 2009 |
Utility of endtidal carbon dioxide monitoring in detection of hypoxia during sedation for brain magnetic resonance imaging in children with developmental disabilities.
Topics: Anesthetics, Intravenous; Brain; Carbon Dioxide; Child; Child, Preschool; Conscious Sedation; Develo | 2011 |
A novel airway monitor for the nonsecured airway during magnetic resonance imaging in children.
Topics: Airway Obstruction; Developmental Disabilities; Humans; Hypnotics and Sedatives; Oropharynx; Pentoba | 2011 |
Oropharyngeal airway diameter during sedation in children with and without developmental delay.
Topics: Airway Obstruction; Case-Control Studies; Child; Child, Preschool; Developmental Disabilities; Human | 2001 |